.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 6,291,184

« Back to Dashboard

Details for Patent: 6,291,184

Title: Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex
Abstract:A method for identifying nucleic acid ligands to target molecules using the SELEX procedure wherein the candidate nucleic acids contain photoreactive groups and nucleic acid ligands identified thereby are claimed. The complexes of increased affinity nucleic acids and target molecules formed in the procedure are crosslinked by irradiation to facilitate separation from unbound nucleic acids. In other methods partitioning of high and low affinity nucleic acids is facilitated by primer extension steps as shown in the figure in which chain termination nucleotides, digestion resistant nucleotides or nucleotides that allow retention of the cDNA product on an affinity matrix are differentially incorporated into the cDNA products of either the high or low affinity nucleic acids and the cDNA products are treated accordingly to amplification, enzymatic or chemical digestion or by contact with an affinity matrix.
Inventor(s): Gold; Larry (Boulder, CO), Willis; Michael (Louisville, CO), Koch; Tad (Boulder, CO), Ringquist; Steven (Lyons, CO), Jensen; Kirk (Boulder, CO), Atkinson; Brent (Boulder, CO)
Assignee: SomaLogic, Inc. (Boulder, CA)
Filing Date:Dec 13, 1999
Application Number:09/459,553
Claims:1. A method for detecting the presence of a target molecule that is associated with a disease state in a biological substance which may contain said target molecule comprising:

a) exposing a biological substance which may contain said target molecule that is associated with a disease state to a nucleic acid ligand identified according to the method comprising:

i) identifying a nucleic acid ligand that photocrosslinks to a target molecule from a candidate mixture of nucleic acids, wherein each member of said candidate mixture contains a photoreactive group, said method comprising:

1) contacting said candidate mixture of nucleic acids with a first biological substance which contains a target molecule that is associated with said disease state, wherein nucleic acids having an increased affinity to a molecule of said first biological substance relative to the candidate mixture form nucleic acid-molecule complexes with said molecule;

2) irradiating said complexes, wherein said nucleic acid and molecule photocrosslink;

3) partitioning the photocrosslinked nucleic acid-molecule complexes from the remainder of the candidate mixture; and

4) identifying nucleic acid ligands that photocrosslink to said target molecule;

ii) contacting a second biological substance which does not contain said target molecule that is associated with said disease state with said nucleic acid ligands identified in step 4), wherein the nucleic acids with affinity to a molecule that is not associated with the disease state in the second biological substance is removed; and

iii) amplifying the remaining nucleic acids with specific affinity to said target molecule that is associated with a disease state to yield a mixture of nucleic acids enriched for nucleic acids with relatively higher affinity and specificity for binding to said target molecule that is associated with said disease state, whereby a nucleic acid ligand to a target molecule that is associated with a disease state in a biological substance is identified;

b) irradiating said biological substance containing said nucleic acid ligand; and

c) detecting whether a nucleic acid ligand-molecule complex has been formed, whereby said target molecule that is associated with said disease state is detected.

2. A method for detecting the presence of a target molecule that is associated with a disease state in a biological substance which may contain said molecule comprising:

a) exposing a biological substance which may contain said target molecule that is associated with a disease state to a nucleic acid ligand identified according to a method comprising:

i) identifying a nucleic acid ligand that photocrosslinks to a target molecule from a candidate mixture of nucleic acids, said method comprising:

1) contacting said candidate mixture of nucleic acids with a first biological substance which contains a target molecule that is associated with said disease state, wherein nucleic acids having an increased affinity to a molecule of said first biological substance relative to the candidate mixture form nucleic acid-molecule complexes with said molecule;

2) partitioning the complexed increased affinity nucleic acids from the remainder of the candidate mixture;

3) amplifying the increased affinity nucleic acids to yield a ligand-enriched mixture of nucleic acids,

4) incorporating photoreactive groups into said amplified increased affinity nucleic acids;

5) irradiating said increased affinity nucleic acids, wherein said nucleic acid-molecule complexes photocrosslink;

6) partitioning the photocrosslinked nucleic acid-molecule complexes from the remainder of the candidate mixture; and

7) identifying nucleic acid ligands that photocrosslink to the molecule;

ii) contacting a second biological substance which does not contain said target molecule that is associated with said disease with said nucleic acid ligands identified in step vii), wherein the nucleic acids with affinity to a molecule that is not associated with said disease is removed; and

iii) amplifying the remaining nucleic acids with specific affinity to said target molecule that is associated with said disease state to yield a mixture of nucleic acids enriched for nucleic acids with relatively higher affinity and specificity for binding to said target molecule that is associated with said disease state, whereby nucleic acid ligands to a target molecule that is associated with a disease state in a biological substance is identified;

b) irradiating said biological substance containing said nucleic acid ligand;

c) detecting whether a nucleic acid ligand-molecule complex has been formed, whereby said target molecule that is associated with said disease state is detected.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc